“…In study design, two studies [31,37] were randomized controlled trials (RCTs), so they were rated "strong", and eleven studies [18-20, 32-36, 38-40] were cohort studies, so they were rated "medium". In confounders, two of the thirteen studies [35,40] were rated as "strong", ve as "medium" [18,34,36,38,39] and the remaining six [19,20,[31][32][33]37] as "weak". For two RCTs [31,37], the authors did not report whether confounding factors were balanced at baseline, so they were rated "weak".…”